LCS COMPLETE RPS Femoral Implants — Class II medical device recall Z-1672-2015
Terminated recall by DePuy Orthopaedics, Inc., reported 2015-06-03, distributed nationwide. The LCS COMPLETE RPS Knee System has higher rates of revision in Australia when the native patella is not resu
| Recall number | Z-1672-2015 |
|---|---|
| Product type | Medical device |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | DePuy Orthopaedics, Inc., Warsaw, IN, United States |
| Recall initiated | 2015-03-04 |
| Classified | 2015-05-26 |
| Reported by FDA | 2015-06-03 |
| Terminated | 2015-10-30 |
| Distributed | Nationwide (US) |
| Countries outside the US | AT, AU, BE, CA, CH, FR, GB, GR, IE, IL, IT, KR, LU, MY, NL, NO, NZ, TH, ZA |
| Quantity | 19,059 |
| Model numbers | 129411010, 129411020, 129411030, 129411040, 129411050, 129411060, 129411070, 129412010, 129412020, 129412030, 129412040, 129412050, 129412060, 129412070, 129495040, 129495050, 129495060, 129496040, 129496050, 129496060 |
Product
LCS COMPLETE RPS Femoral Implants, various sizes and orientation. Knee prosthesis component for orthopedic surgery.
Reason for recall
The LCS COMPLETE RPS Knee System has higher rates of revision in Australia when the native patella is not resurfaced when compared to other unresurfaced PS implants. If the LCS COMPLETE RPS Knee System is implanted and the native patella is not resurfaced, the patient may experience patello-femoral pain, potentially requiring a secondary procedure.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-1672-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.